Form 4: Biogen Executive Susan H. Alexander Reports Stock Transactions
SEC Form 4 Filing
EVP and Chief Legal Officer of Biogen, Susan H. Alexander, reports acquisition and disposal of common stock and restricted stock units.
Summary
- Susan H. Alexander, EVP and Chief Legal Officer of Biogen, filed a Form 4 detailing changes in beneficial ownership.
- On February 7, 2025, Alexander acquired 2,190 and 1,940 shares of common stock through the vesting of restricted stock units.
- Also on February 7, 2025, Alexander disposed of 643 and 591 shares of common stock to cover tax obligations at a price of $141.35.
- Following these transactions, Alexander directly owns 34,497 shares of common stock and indirectly owns 20,082 shares through a trust.
- Alexander also holds 3,880 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which doesn't inherently convey positive or negative sentiment. It's a neutral reporting of facts.
Industry Context
Executive stock transactions are a routine part of corporate governance and compensation practices. They provide insights into executive sentiment but are often driven by pre-arranged plans or tax considerations.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation activities.
Key Dates
| Date | Description |
|---|---|
| 02/08/2023 | Grant date for restricted stock units vesting in three equal annual installments commencing one year after this date. |
| 02/07/2024 | Grant date for restricted stock units vesting in three equal annual installments commencing one year after this date. |
| 02/06/2025 | Grant date for 14,750 restricted stock units vesting in three equal yearly installments beginning on the first anniversary of this date. |
| 02/06/2025 | Date of earliest transaction. |
| 02/07/2025 | Date of stock transactions (acquisition and disposal). |
| 02/10/2025 | Date of Form 4 filing. |
| 02/08/2026 | Expiration date for restricted stock units. |
| 02/07/2027 | Expiration date for restricted stock units. |
| 02/06/2028 | Expiration date for restricted stock units. |
Keywords
Form 4, Biogen, Stock, Alexander, BIIB, RSU, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.